bf/NASDAQ:IMGN_icon.jpeg

NASDAQ:IMGN

ImmunoGen, Inc.

  • Stock

USD

Last Close

31.23

09/02 20:58

Market Cap

8.73B

Beta: 0.94

Volume Today

19.31M

Avg: 6.23M

PE Ratio

−109.77

PFCF: −41.03

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Jun '14
Jun '15
Jun '16
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
average inventory
1.83M
-
2.94M
61.10%
1.92M
34.72%
1.55M
19.34%
972.50K
37.24%
-7.75M
896.45%
-24.60M
217.62%
-31.54M
28.19%
-25.82M
18.11%
-2.53M
90.22%
average payables
4.66M
-
6.48M
39.07%
9.82M
51.64%
9.70M
1.24%
10.04M
3.44%
9.96M
0.72%
10.65M
6.88%
9.74M
8.58%
13.99M
43.66%
31.89M
128.04%
average receivables
2.67M
-
4.51M
68.86%
4.05M
10.34%
5.55M
37.09%
3.76M
32.22%
8.65M
129.97%
19.66M
127.31%
24.87M
26.53%
18.21M
26.78%
15.95M
12.41%
book value per share
0.89
-
0.41
53.93%
-0.93
328.65%
-1.76
88.16%
-0.18
89.60%
0.09
146.76%
-0.51
701.47%
0.51
199.07%
1.58
210.61%
0.61
61.10%
capex per share
-0.10
-
-0.09
9.86%
-0.12
38.24%
-0.08
35.93%
-0.01
85.11%
-0.04
229.41%
-0.02
48.83%
-0.01
72.86%
-0.01
33.63%
-0.01
22.69%
capex to depreciation
-1.78
-
-1.35
24.33%
-1.95
44.62%
-1.11
43.19%
-0.19
83.09%
-0.71
278.23%
-0.71
0.22%
-0.44
38.21%
-0.71
62.89%
-0.77
7.60%
capex to operating cash flow
0.15
-
0.13
11.97%
0.08
37.93%
0.05
44.03%
-0.15
412.89%
0.03
121.59%
0.03
2.14%
0.01
63.77%
0.01
27.43%
0.01
29.88%
capex to revenue
-0.14
-
-0.09
36.47%
-0.17
99.22%
-0.14
20.86%
-0.01
92.94%
-0.10
908.41%
-0.03
64.53%
-0.01
79.96%
-0.02
196.16%
-0.01
38.92%
cash per share
1.66
-
3.23
94.23%
2.82
12.85%
1.84
34.79%
2.72
48.26%
1.87
31.20%
1.19
36.59%
1.67
40.39%
2.32
39.22%
1.08
53.29%
days of inventory on hand
10.07
-
9.58
4.79%
2.25
76.49%
5.66
151.26%
2.71
52.11%
-34.70
1,379.68%
-104.13
200.14%
-96.82
7.02%
33.59K
-
days payables outstanding
16.45
-
26.58
61.61%
28.60
7.60%
20.39
28.69%
22.36
9.67%
23.86
6.67%
31.66
32.70%
30.38
4.04%
94.06K
-
days sales outstanding
19.65
-
24.76
25.97%
13.94
43.68%
66.08
373.96%
16.53
74.98%
81.84
395.05%
120.89
47.71%
62.07
48.66%
72.77
17.24%
60.32
17.10%
debt to assets
0.06
-
0.42
575.28%
0.49
16.61%
-0.02
104.53%
-0.03
42.31%
0.11
462.25%
0.07
40.94%
0.04
46.91%
0.04
22.30%
debt to equity
0.55
-
-1.48
367.25%
-0.63
57.12%
0.36
157.36%
-0.78
314.03%
-0.35
54.72%
0.27
175.62%
0.06
78.37%
0.10
69.59%
dividend yield
earnings yield
-0.07
-
-0.05
30.32%
-0.54
992.33%
-0.88
64.54%
-0.15
82.69%
-0.25
63.62%
-0.16
35.54%
-0.06
63.57%
-0.10
66.37%
-0.18
81.49%
enterprise value
870.69M
-
959.12M
10.16%
122.86M
87.19%
17.67M
85.62%
363.56M
1,957.54%
411.55M
13.20%
608.49M
47.85%
866.22M
42.36%
1.07B
23.48%
998.12M
6.69%
enterprise value over ebitda
-12.17
-
-17.34
42.48%
-0.99
94.27%
-0.14
85.81%
-6.54
4,533.42%
-2.68
58.99%
-9.26
245.20%
-44.01
375.36%
-8.48
80.73%
-4.59
45.89%
ev to operating cash flow
-16.23
-
-17.35
6.89%
-0.99
94.31%
-0.12
87.45%
47.56
38,490.00%
-2.47
105.20%
-6.89
178.45%
-11.02
60.00%
-6.31
42.70%
-4.34
31.21%
ev to sales
14.54
-
11.21
22.87%
2.05
81.74%
0.36
82.25%
3.15
766.67%
7.65
142.84%
7.40
3.29%
6.55
11.48%
15.31
133.86%
9.18
40.08%
free cash flow per share
-0.72
-
-0.73
0.77%
-1.55
112.70%
-1.71
10.59%
0.07
103.88%
-1.23
1,942.51%
-0.62
49.86%
-0.45
26.58%
-0.83
83.55%
-0.91
9.97%
free cash flow yield
-0.06
-
-0.05
16.96%
-0.50
893.07%
-0.84
66.96%
0.01
101.24%
-0.26
2,560.52%
-0.12
52.91%
-0.07
41.84%
-0.11
59.56%
-0.18
64.52%
graham net net
0.66
-
0.06
90.85%
-1.39
2,398.39%
-2.11
51.90%
-0.42
80.21%
-0.15
64.52%
-0.89
497.19%
0.17
119.23%
1.35
692.22%
0.41
69.75%
graham number
4.08
-
2.55
37.58%
5.89
131.29%
8.43
43.20%
2.00
76.22%
1.52
24.31%
3.08
103.17%
2.08
32.50%
5.07
143.82%
3.49
31.30%
income quality
0.75
-
0.91
21.09%
0.86
5.58%
0.91
5.88%
-0.08
108.75%
0.99
1,337.87%
0.85
13.91%
1.77
108.80%
1.22
31.36%
1.03
15.24%
intangibles to total assets
0
-
0
0
0
0
0
0
0
0
0
interest coverage
428.33
-
-10.02
102.34%
-6.15
38.59%
-3.53
-
-14.96
324.18%
-5.43
63.71%
-5.84
7.53%
-9.51
62.88%
-53.04
457.61%
interest debt per share
-0.00
-
0.29
14,895.21%
1.61
457.58%
1.11
30.91%
0.10
90.65%
0.01
90.22%
0.30
2,801.71%
0.27
9.52%
0.15
42.06%
0.08
50.60%
inventory turnover
36.26
-
38.08
5.03%
161.98
325.35%
64.47
60.20%
134.62
108.82%
-10.52
107.81%
-3.51
66.68%
-3.77
7.55%
0.01
-
invested capital
0.55
-
-1.48
367.25%
-0.63
57.12%
0.36
157.36%
-0.78
314.03%
-0.35
54.72%
0.27
175.62%
0.06
78.37%
0.10
69.59%
market cap
1.01B
-
1.24B
22.14%
267.89M
78.35%
177.63M
33.69%
628.62M
253.88%
671.74M
6.86%
757.87M
12.82%
1.14B
49.92%
1.53B
34.63%
1.26B
17.76%
net current asset value
52.64M
-
-610K
101.16%
-123.20M
20,096.89%
-175.37M
42.34%
-45.46M
74.08%
-21.56M
52.58%
-135.56M
528.84%
28.35M
120.92%
278.57M
882.48%
82.03M
70.55%
net debt to ebitda
1.99
-
5.03
152.86%
1.17
76.65%
1.28
8.83%
4.77
273.14%
1.70
64.44%
2.27
34.04%
13.72
503.49%
3.65
73.42%
1.19
67.23%
net income per share
-0.83
-
-0.71
15.44%
-1.65
133.96%
-1.80
8.98%
-0.98
45.61%
-1.20
22.52%
-0.82
31.37%
-0.38
54.02%
-0.72
91.39%
-0.88
21.32%
operating cash flow per share
-0.63
-
-0.64
2.39%
-1.43
122.70%
-1.64
14.46%
0.08
104.76%
-1.19
1,625.46%
-0.60
49.90%
-0.45
25.09%
-0.82
84.13%
-0.91
10.25%
payables turnover
22.20
-
13.73
38.12%
12.76
7.06%
17.90
40.23%
16.32
8.82%
15.30
6.25%
11.53
24.64%
12.01
4.20%
0.00
-
receivables turnover
18.57
-
14.74
20.62%
26.18
77.56%
5.52
78.90%
22.08
299.72%
4.46
79.80%
3.02
32.30%
5.88
94.77%
5.02
14.71%
6.05
20.63%
research and ddevelopement to revenue
1.79
-
1.31
26.83%
2.45
87.39%
2.91
18.68%
1.21
58.35%
3.23
166.94%
1.39
56.92%
0.87
37.78%
2.16
149.75%
1.96
9.33%
return on tangible assets
-0.43
-
-0.19
55.16%
-0.50
158.54%
-0.79
57.50%
-0.33
58.66%
-0.57
74.21%
-0.52
8.73%
-0.19
63.75%
-0.28
51.26%
-0.64
124.90%
revenue per share
0.70
-
0.99
41.89%
0.69
30.61%
0.56
19.05%
1.18
110.80%
0.38
67.33%
0.55
44.25%
0.75
35.39%
0.34
54.88%
0.43
26.57%
roe
-0.94
-
-1.73
83.54%
1.77
202.32%
1.03
42.08%
5.37
423.24%
-14.06
362.01%
1.60
111.41%
-0.74
146.42%
-0.46
38.38%
-1.43
211.87%
roic
-0.94
-
-1.10
16.87%
-3.62
228.75%
2.35
164.82%
3.35
42.62%
-63.44
1,994.53%
4.41
106.95%
-1.51
134.13%
-0.37
75.47%
-1.19
222.83%
sales general and administrative to revenue
0.41
-
0.33
19.22%
0.62
86.44%
0.79
28.78%
0.29
62.93%
0.68
132.27%
0.47
31.43%
0.29
37.64%
0.63
114.96%
shareholders equity per share
0.89
-
0.41
53.93%
-0.93
328.65%
-1.76
88.16%
-0.18
89.60%
0.09
146.76%
-0.51
701.47%
0.51
199.07%
1.58
210.61%
0.61
61.10%
stock based compensation to revenue
0.27
-
0.18
31.57%
0.37
101.83%
0.41
11.59%
0.10
76.29%
0.31
218.36%
0.17
44.86%
0.11
37.14%
0.25
131.10%
0.24
5.87%
tangible asset value
75.70M
-
35.10M
53.63%
-81.14M
331.15%
-152.85M
88.37%
-17.89M
88.29%
11.94M
166.73%
-76.12M
737.42%
89.57M
217.67%
325.59M
263.50%
155.83M
52.14%
tangible book value per share
0.89
-
0.41
53.93%
-0.93
328.65%
-1.76
88.16%
-0.18
89.60%
0.09
146.76%
-0.51
701.47%
0.51
199.07%
1.58
210.61%
0.61
61.10%
working capital
121.01M
-
242.30M
100.24%
184.75M
23.75%
120.57M
34.74%
211.34M
75.28%
192.19M
9.06%
98.81M
48.59%
171.53M
73.59%
377.81M
120.25%
153.28M
59.43%

All numbers in USD (except ratios and percentages)